BRPI0907191A2 - Solução, método para preparar uma solução, método para aumentar a penetração cutânea de imiquimod ou um análogo do mesmo - Google Patents
Solução, método para preparar uma solução, método para aumentar a penetração cutânea de imiquimod ou um análogo do mesmoInfo
- Publication number
- BRPI0907191A2 BRPI0907191A2 BRPI0907191-1A BRPI0907191A BRPI0907191A2 BR PI0907191 A2 BRPI0907191 A2 BR PI0907191A2 BR PI0907191 A BRPI0907191 A BR PI0907191A BR PI0907191 A2 BRPI0907191 A2 BR PI0907191A2
- Authority
- BR
- Brazil
- Prior art keywords
- imiquimod
- solution
- analog
- preparing
- increasing
- Prior art date
Links
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 title 2
- 229960002751 imiquimod Drugs 0.000 title 2
- 230000035515 penetration Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1110608P | 2008-01-15 | 2008-01-15 | |
| PCT/US2009/000218 WO2009091541A1 (en) | 2008-01-15 | 2009-01-14 | Imiquimod formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0907191A2 true BRPI0907191A2 (pt) | 2015-07-14 |
Family
ID=40851217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0907191-1A BRPI0907191A2 (pt) | 2008-01-15 | 2009-01-14 | Solução, método para preparar uma solução, método para aumentar a penetração cutânea de imiquimod ou um análogo do mesmo |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090182004A1 (pt) |
| EP (1) | EP2237805A1 (pt) |
| JP (1) | JP2011510001A (pt) |
| KR (1) | KR20100117077A (pt) |
| CN (1) | CN101909664A (pt) |
| AU (1) | AU2009205700A1 (pt) |
| BR (1) | BRPI0907191A2 (pt) |
| CA (1) | CA2708203A1 (pt) |
| MX (1) | MX2010007410A (pt) |
| RU (1) | RU2010123618A (pt) |
| WO (1) | WO2009091541A1 (pt) |
| ZA (1) | ZA201004145B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100160368A1 (en) * | 2008-08-18 | 2010-06-24 | Gregory Jefferson J | Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy |
| BRPI0923164A2 (pt) | 2008-12-19 | 2016-01-26 | Graceway Pharmaceuticals Llc | formulações de imiquimod com concentração de dosagem menos e regimes de dosagem curtos para o tratamento de ceratose actínica. |
| WO2010088924A1 (en) * | 2009-02-06 | 2010-08-12 | Telormedix Sa | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| GEP20156418B (en) | 2009-07-13 | 2016-01-11 | Medicis Pharmaceutical Corp | Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts |
| NZ610136A (en) * | 2010-11-04 | 2015-06-26 | 442 Ventures Llc | Composition and method for treating skin conditions |
| CA2969590A1 (en) * | 2014-12-03 | 2016-06-09 | Rxi Pharmaceuticals Corporation | Methods for the treatment of alopecia areata utilizing gene modulation approaches |
| KR101729236B1 (ko) * | 2015-06-01 | 2017-04-21 | (주)노터스생명과학 | Tlr7 항진제를 포함하는 비만 또는 간질환 예방 및 치료용 약학 조성물 |
| EP4167975A4 (en) * | 2020-06-23 | 2024-07-24 | Celista Pharmaceuticals Llc | IMIQUIMOD CO-CRYSTALS |
| WO2021262850A1 (en) * | 2020-06-23 | 2021-12-30 | Celista Pharmaceuticals Llc | Antiviral therapy with imiquimod and cocrystals thereof |
| CN116942609A (zh) * | 2021-11-05 | 2023-10-27 | 苏州百迈生物医药有限公司 | 一种咪喹莫特混悬液制剂及其制备方法和应用 |
| CN115120738B (zh) * | 2022-07-20 | 2023-05-12 | 山东大学 | 一种咪喹莫特前药纳米粒及其制备方法和应用 |
| CN119215159A (zh) * | 2024-09-24 | 2024-12-31 | 深圳市格茵莱生物科技有限公司 | 树突状细胞多抗原负载免疫治疗方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL73534A (en) * | 1983-11-18 | 1990-12-23 | Riker Laboratories Inc | 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds |
| US5238944A (en) * | 1988-12-15 | 1993-08-24 | Riker Laboratories, Inc. | Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine |
| GB8928281D0 (en) * | 1989-12-14 | 1990-02-21 | Smith Kline French Lab | Compounds |
| JPH10298181A (ja) * | 1997-04-25 | 1998-11-10 | Sumitomo Pharmaceut Co Ltd | タイプ２ヘルパーｔ細胞選択的免疫応答抑制剤 |
| US6245776B1 (en) * | 1999-01-08 | 2001-06-12 | 3M Innovative Properties Company | Formulations and methods for treatment of mucosal associated conditions with an immune response modifier |
| US20020058674A1 (en) * | 1999-01-08 | 2002-05-16 | Hedenstrom John C. | Systems and methods for treating a mucosal surface |
| CA2510375A1 (en) * | 2002-12-20 | 2004-07-15 | 3M Innovative Properties Company | Aryl / hetaryl substituted imidazoquinolines |
| US20040143026A1 (en) * | 2002-12-31 | 2004-07-22 | Shah Kishore R. | Bioadhesive hydrophilic composition for treatment of mammalian skin |
| US20070196453A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs |
| US20070264317A1 (en) * | 2006-05-15 | 2007-11-15 | Perrigo Israel Pharmaceuticals Ltd. | Imiquimod cream formulation |
| US20080280943A1 (en) * | 2007-03-23 | 2008-11-13 | Slade Herbert B | Methods and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders |
-
2009
- 2009-01-14 WO PCT/US2009/000218 patent/WO2009091541A1/en not_active Ceased
- 2009-01-14 RU RU2010123618/15A patent/RU2010123618A/ru not_active Application Discontinuation
- 2009-01-14 US US12/319,978 patent/US20090182004A1/en not_active Abandoned
- 2009-01-14 AU AU2009205700A patent/AU2009205700A1/en not_active Abandoned
- 2009-01-14 KR KR1020107018105A patent/KR20100117077A/ko not_active Withdrawn
- 2009-01-14 EP EP09702943A patent/EP2237805A1/en not_active Withdrawn
- 2009-01-14 MX MX2010007410A patent/MX2010007410A/es not_active Application Discontinuation
- 2009-01-14 JP JP2010543127A patent/JP2011510001A/ja not_active Withdrawn
- 2009-01-14 BR BRPI0907191-1A patent/BRPI0907191A2/pt not_active IP Right Cessation
- 2009-01-14 CA CA2708203A patent/CA2708203A1/en not_active Abandoned
- 2009-01-14 CN CN2009801022768A patent/CN101909664A/zh active Pending
-
2010
- 2010-06-10 ZA ZA2010/04145A patent/ZA201004145B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2010123618A (ru) | 2012-02-27 |
| KR20100117077A (ko) | 2010-11-02 |
| JP2011510001A (ja) | 2011-03-31 |
| US20090182004A1 (en) | 2009-07-16 |
| AU2009205700A1 (en) | 2009-07-23 |
| WO2009091541A1 (en) | 2009-07-23 |
| MX2010007410A (es) | 2011-02-25 |
| EP2237805A1 (en) | 2010-10-13 |
| CN101909664A (zh) | 2010-12-08 |
| ZA201004145B (en) | 2011-02-23 |
| CA2708203A1 (en) | 2009-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0907191A2 (pt) | Solução, método para preparar uma solução, método para aumentar a penetração cutânea de imiquimod ou um análogo do mesmo | |
| EP2538988A4 (en) | METHOD FOR TISSUE-DECELULARIZATION | |
| BR112014010186A2 (pt) | formulação farmacêutica estável, kit, composição farmacêutica, método para preparar uma formulação farmacêutica, e, método para tratar um humano ou animal | |
| BR112012001238A2 (pt) | método para carbonetar, nitretar ou nitrocarbonetar um artigo | |
| BRPI1013705A2 (pt) | compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica | |
| BR112013033811A2 (pt) | composição, método de preparação da composição, e, composto | |
| HRP20171870T1 (hr) | Sastavi i postupci za ubrzavanje rasta mišića | |
| BRPI0919937A2 (pt) | composto, e, método para melhorar a atividade de adjuvante de uma imidazoquinolina | |
| SMT201700605T1 (it) | Metodo per la preparzione di tessuti, in particolare di tessuti adiposi | |
| BR112012030229A2 (pt) | ferramenta cirúgica de implantação radial | |
| BR112013012309A2 (pt) | composto, composição, métodos de tratamento e usos de um composto | |
| BR112014010164A2 (pt) | implante de tecido duro | |
| BR112013009970A2 (pt) | método para determinar uma característica do ritmo circadiano de um paciente. | |
| BR112012029746A2 (pt) | composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação | |
| BR112012016912A2 (pt) | composição de gel de diagnóstico, método para preparar uma composição de gel de diagnóstico | |
| BRPI0911077A2 (pt) | método para tratamento de biomassa | |
| BR112012028719A2 (pt) | composição de tratamento de superfície dura, método para fornecer um efeito antimicrobiano a uma superfície dura e uso de uma combinação | |
| BRPI0910879A2 (pt) | preparação estabilizada de oleossomas, formulação acabada e método de produção das mesmas | |
| SG11201501558RA (en) | Method for maintaining organ or tissue for transplantation use for long period | |
| EP2639215A4 (en) | SULFUR OF KUKOAMIN B, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE | |
| BRPI0907950A2 (pt) | Tratamento de hiperglicemia com 25-hidroxivitamina d3 | |
| BR112013013581A2 (pt) | composição de graxa, componente mecânico, uso da composição de graxa, e, método para preparação de uma composição de graxa | |
| BRPI1011912A2 (pt) | l-serina para uso como medicamento para prevenir e/ou tratar uma reação inflamatória da pele. | |
| BR112014017445A2 (pt) | composição, uso de uma composição, corpo lignocelulósico, e, método para preparar uma composição | |
| BR112014013609A2 (pt) | composição antimicrobiana sólida, método da desinfecção de uma superfície e utilização de uma composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |